A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT06598943 · RECRUITING
Trial details
- NCT number
- NCT06598943
- Sponsor
- Eli Lilly and Company
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-10
- Primary completion
- 2027-12-01
- Enrollment
- 143
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.